131 results on '"A. Rychter"'
Search Results
2. Rescuing Mele/Robb-Style Cases
- Author
-
Rychter, Pablo, primary
- Published
- 2023
- Full Text
- View/download PDF
3. Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality
- Author
-
Rychter, Anna, primary, Miniszewska, Joanna, additional, and Góra-Tybor, Joanna, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Rescuing Mele/Robb-Style Cases
- Author
-
Pablo Rychter
- Subjects
Philosophy - Abstract
A good part of the philosophical debate on free will and moral responsibility in the last fifty years has revolved around so-called Frankfurt-style cases. One of the most important milestones in this debate is the case described by Mele and Robb (1998), which was intended to avoid some earlier objections directed at Frankfurt’s original argument. However, the success of Mele and Robb’s case has been contested by Pereboom (2001), Widerker (2003), and Moya (2003, 2017), among others. The present paper aims to vindicate Mele and Robb’s (and Frankfurt’s) general argument by describing a variation of their case that overcomes or avoids the objections of those authors.
- Published
- 2023
5. Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality
- Author
-
Anna Rychter, Joanna Miniszewska, and Joanna Góra-Tybor
- Subjects
Psychiatry and Mental health ,Social Psychology ,Biological Psychiatry ,General Psychology - Abstract
Background The introduction of BCR-ABL tyrosine kinase inhibitors (TKIs) to chronic myeloid leukemia (CML) therapy has revolutionized the treatment of this disease. Although regular TKI intake is a prerequisite for successful therapy, it has been shown that a significant proportion of patients are non-compliant. Recently there is growing evidence that personality traits may influenced the tendency for non-adherence to treatment in patients with chronic diseases. As far as we know, such a relationship in patients with CML has not been examined, yet. The aim of our study was to determine if personality traits favor non-adherence to treatment recommendations. We investigated the relationship between five-factor model personality factors (conscientiousness, neuroticism, agreeableness, extraversion, and openness) and medication non-adherence. We also checked if the patients with type A and type D personality, were at higher risk of poor medication adherence. Methods The following tools were used: self-constructed survey, the NEO-Five Factor Inventory, the Framingham Type A Scale, the D-Scale 14. The study included 140 CML patients treated with imatinib, dasatinib, or nilotinib. Results 39% of patients reported skipping at least one dose of medication in the month prior to follow-up visit. 51% admitted to skipping such doses from the start of their treatment to the time at which our assessment was performed. We did not find any relationship between the mean values of the analyzed factors of the Big Five (neuroticism, extraversion, openness, agreeableness, conscientiousness) and adherence. However, our analysis revealed that CML patients who admitted to missing doses of drugs during the entire course of treatment demonstrated greater intensity of type A personality traits (p = 0.020). Regarding both factors of type D personality, it was revealed that higher level of negative affectivity significantly decreased the adherence (p = 0.020). Conclusion The results of our study indicate that screening for type D and A personalities may help to identify patients who are at higher risk of poor medication adherence.
- Published
- 2023
6. Ecotoxicity and bioremediation potential assessment of soil from oil refinery station area
- Author
-
Zawierucha, Iwona, primary, Malina, Grzegorz, additional, Herman, Barbara, additional, Rychter, Piotr, additional, Biczak, Robert, additional, Pawlowska, Barbara, additional, Bandurska, Katarzyna, additional, and Barczynska, Renata, additional
- Published
- 2022
- Full Text
- View/download PDF
7. Poly(methylene-co-cyanoguanidine) as an Eco-friendly Nitrogen Fertilizer with Prolonged Activity
- Author
-
Kamila Lewicka, Diana Rogacz, Igor Lacík, and Piotr Rychter
- Subjects
Environmental Engineering ,Materials science ,food.ingredient ,Polymers and Plastics ,chemistry.chemical_element ,Raphanus ,02 engineering and technology ,engineering.material ,food ,020401 chemical engineering ,Materials Chemistry ,Food science ,0204 chemical engineering ,Incubation ,biology ,fungi ,food and beverages ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Nitrogen ,Avena ,chemistry ,Shoot ,engineering ,Composition (visual arts) ,Fertilizer ,Ecotoxicity ,0210 nano-technology - Abstract
Poly(methylene-co-cyanoguanidine), PMCG, is an oligomeric polycation that has found its application in the waste-water treatment as well as in preparation of polyelectrolyte complex microcapsules for biomedical purposes. Considering the nitrogen-rich composition of repeating unit, PMCG may be a valuable polycation utilized as a novel slow-release fertilizer. The aim of this study was to evaluate the potential of PMCG as a nitrogen fertilizer during its 6-month incubation in the soil. Monocotyledonous oat (Avena sativa) and dicotyledonous radish (Raphanus sativus L.) were selected as representative model plants for plant growth test. The effect of PMCG on plant growth and development was dependent on both the PMCG concentration and time of incubation. An increase in the nitrogen amount in green parts of plants demonstrated the uptake of the plant-available form of nitrogen released from PMCG incubated in the soil. This resulted in an increased percentage of fresh matter and shoot height of the tested plants during their exposure to PMCG. Ecotoxicological impact of PMCG in the soil during incubation period against bacteria Allivibrio fischeri and crustacean Heterocypris incongruens was also assessed. PMCG was found as the potential polymer fertilizer that does not require special treatment and can be used as it is for the prolonged release of nitrogen in agriculture.
- Published
- 2019
8. A study of dynamic adsorption of propylene and ethylene emitted from the process of coal self-heating
- Author
-
Adam Smoliński and Karolina Wojtacha-Rychter
- Subjects
Solid Earth sciences ,Materials science ,Ethylene ,020209 energy ,geology ,lcsh:Medicine ,02 engineering and technology ,Coal dust ,complex mixtures ,Article ,Granulation ,chemistry.chemical_compound ,Adsorption ,020401 chemical engineering ,0202 electrical engineering, electronic engineering, information engineering ,Coal ,0204 chemical engineering ,lcsh:Science ,Bituminous coal ,Multidisciplinary ,business.industry ,lcsh:R ,geology.rock_type ,Natural hazards ,Grain size ,respiratory tract diseases ,Environmental sciences ,Chemical engineering ,chemistry ,lcsh:Q ,business ,Saturation (chemistry) - Abstract
The gaseous products emitted in the self-heating process constitute one of the parameters suggested for detecting coal spontaneous combustion in underground mining. The objective of the study is to investigate the changes of ethylene and propylene content in a gaseous mixture which flowed through a fixed bed column filled with bituminous coal of different grain size. The mixtures of fire gases were obtained from laboratory simulated heating of coal at the temperatures of 373 K, 423 K, 473 K and 523 K. Hydrocarbons of various initial concentrations were introduced to the adsorption column at the constant flow rate of 2∙10−7 m3/s. The experimental findings show that decreasing the adsorbent granulation and gases concentration causes an extended breakthrough and coal bed saturation times. In all the tests, the saturation time was gained faster for ethylene than for propylene. Thus, the content of tested hydrocarbons, which are some of the indicators for assessing the degree of the coal self-heating process, in mine air may change in time as a result of the adsorption phenomenon. It occurs particularly at the early stage of the self-heating process and in places where coal dust has been left.
- Published
- 2019
9. Mortality of post-settlement clams Rangia cuneata (Mactridae, Bivalvia) at an early stage of invasion in the Vistula Lagoon (South Baltic) due to biotic and abiotic factors
- Author
-
Leszek Rolbiecki, Agata Rychter, Krzysztof Pawlikowski, Aleksander Drgas, and Ryszard Kornijów
- Subjects
0106 biological sciences ,Abiotic component ,Mactridae ,education.field_of_study ,Biomass (ecology) ,animal structures ,Resistance (ecology) ,Ecology ,010604 marine biology & hydrobiology ,Field experiment ,Population ,Aquatic Science ,Biology ,Bivalvia ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Predation ,education - Abstract
The clam Rangia cuneata, originating from the Gulf of Mexico, was recorded in the Vistula Lagoon for the first time in the early 2010s, and quickly became the dominant component of the zoobenthic biomass. To assess mortality as a factor potentially controlling the growth of Rangia population, a year-long field experiment involving marked bivalves placed in sediment-filled trays deployed on the bottom was conducted in 2014 and 2015. Predator-induced mortality of the clams was low in summer, and very high in the winter–spring period. It was inversely proportional to the size of the clams. Such changes can be partially attributed to predation from at least five fish and three duck species, which contained clams in their digestive tracts. Non-predatory mortality particularly affected large individuals, and was highest in spring, several weeks after the end of winter. We hypothesize that it could be caused by persistent low temperatures over several winter months which led to considerable weakening of the condition of clams. A long winter could also reduce their resistance to environmental stress and potential effect of epibionts, as well as increase susceptibility to predation.
- Published
- 2018
10. Effect of porous structure of coal on propylene adsorption from gas mixtures
- Author
-
Wojtacha-Rychter, Karolina, primary, Howaniec, Natalia, additional, and Smoliński, Adam, additional
- Published
- 2020
- Full Text
- View/download PDF
11. Erratum to: Azimuthal asymmetries of charged hadrons produced in high-energy muon scattering off longitudinally polarised deuterons
- Author
-
Adolph, C., primary, Aghasyan, M., additional, Akhunzyanov, R., additional, Alexeev, M. G., additional, Alexeev, G. D., additional, Amoroso, A., additional, Andrieux, V., additional, Anfimov, N. V., additional, Anosov, V., additional, Augsten, K., additional, Augustyniak, W., additional, Austregesilo, A., additional, Azevedo, C. D. R., additional, Badełek, B., additional, Balestra, F., additional, Ball, M., additional, Barth, J., additional, Beck, R., additional, Bedfer, Y., additional, Bernhard, J., additional, Bicker, K., additional, Bielert, E. R., additional, Birsa, R., additional, Bodlak, M., additional, Bordalo, P., additional, Bradamante, F., additional, Braun, C., additional, Bressan, A., additional, Büchele, M., additional, Chang, W.-C., additional, Chatterjee, C., additional, Chiosso, M., additional, Choi, I., additional, Chung, S.-U., additional, Cicuttin, A., additional, Crespo, M. L., additional, Curiel, Q., additional, Dalla Torre, S., additional, Dasgupta, S. S., additional, Dasgupta, S., additional, Denisov, O. Yu., additional, Dhara, L., additional, Donskov, S. V., additional, Doshita, N., additional, Dreisbach, Ch., additional, Duic, V., additional, Dünnweber, W., additional, Dziewiecki, M., additional, Efremov, A., additional, Eversheim, P. D., additional, Eyrich, W., additional, Faessler, M., additional, Ferrero, A., additional, Finger, M., additional, Fischer, H., additional, Franco, C., additional, du Fresne von Hohenesche, N., additional, Friedrich, J. M., additional, Frolov, V., additional, Fuchey, E., additional, Gautheron, F., additional, Gavrichtchouk, O. P., additional, Gerassimov, S., additional, Giarra, J., additional, Giordano, F., additional, Gnesi, I., additional, Gorzellik, M., additional, Grabmüller, S., additional, Grasso, A., additional, Grosse Perdekamp, M., additional, Grube, B., additional, Grussenmeyer, T., additional, Guskov, A., additional, Haas, F., additional, Hahne, D., additional, Hamar, G., additional, von Harrach, D., additional, Heinsius, F. H., additional, Heitz, R., additional, Herrmann, F., additional, Horikawa, N., additional, d’Hose, N., additional, Hsieh, C.-Y., additional, Huber, S., additional, Ishimoto, S., additional, Ivanov, A., additional, Ivanshin, Yu., additional, Iwata, T., additional, Jary, V., additional, Joosten, R., additional, Jörg, P., additional, Kabuß, E., additional, Ketzer, B., additional, Khaustov, G. V., additional, Khokhlov, Yu. A., additional, Kisselev, Yu., additional, Klein, F., additional, Klimaszewski, K., additional, Koivuniemi, J. H., additional, Kolosov, V. N., additional, Kondo, K., additional, Königsmann, K., additional, Konorov, I., additional, Konstantinov, V. F., additional, Kotzinian, A. M., additional, Kouznetsov, O. M., additional, Krämer, M., additional, Kremser, P., additional, Krinner, F., additional, Kroumchtein, Z. V., additional, Kulinich, Y., additional, Kunne, F., additional, Kurek, K., additional, Kurjata, R. P., additional, Lednev, A. A., additional, Lehmann, A., additional, Levillain, M., additional, Levorato, S., additional, Lian, Y.-S., additional, Lichtenstadt, J., additional, Longo, R., additional, Maggiora, A., additional, Magnon, A., additional, Makins, N., additional, Makke, N., additional, Mallot, G. K., additional, Marianski, B., additional, Martin, A., additional, Marzec, J., additional, Matoušek, J., additional, Matsuda, H., additional, Matsuda, T., additional, Meshcheryakov, G. V., additional, Meyer, M., additional, Meyer, W., additional, Mikhailov, Yu. V., additional, Mikhasenko, M., additional, Mitrofanov, E., additional, Mitrofanov, N., additional, Miyachi, Y., additional, Nagaytsev, A., additional, Nerling, F., additional, Neyret, D., additional, Nový, J., additional, Nowak, W.-D., additional, Nukazuka, G., additional, Nunes, A. S., additional, Olshevsky, A. G., additional, Orlov, I., additional, Ostrick, M., additional, Panzieri, D., additional, Parsamyan, B., additional, Paul, S., additional, Peng, J.-C., additional, Pereira, F., additional, Pešek, M., additional, Peshekhonov, D. V., additional, Pierre, N., additional, Platchkov, S., additional, Pochodzalla, J., additional, Polyakov, V. A., additional, Pretz, J., additional, Quaresma, M., additional, Quintans, C., additional, Ramos, S., additional, Regali, C., additional, Reicherz, G., additional, Riedl, C., additional, Roskot, M., additional, Rossiyskaya, N. S., additional, Ryabchikov, D. I., additional, Rybnikov, A., additional, Rychter, A., additional, Salac, R., additional, Samoylenko, V. D., additional, Sandacz, A., additional, Santos, C., additional, Sarkar, S., additional, Savin, I. A., additional, Sawada, T., additional, Sbrizzai, G., additional, Schiavon, P., additional, Schmidt, K., additional, Schmieden, H., additional, Schönning, K., additional, Seder, E., additional, Selyunin, A., additional, Silva, L., additional, Sinha, L., additional, Sirtl, S., additional, Slunecka, M., additional, Smolik, J., additional, Srnka, A., additional, Steffen, D., additional, Stolarski, M., additional, Subrt, O., additional, Sulc, M., additional, Suzuki, H., additional, Szabelski, A., additional, Szameitat, T., additional, Sznajder, P., additional, Takekawa, S., additional, Tasevsky, M., additional, Tessaro, S., additional, Tessarotto, F., additional, Thibaud, F., additional, Thiel, A., additional, Tosello, F., additional, Tskhay, V., additional, Uhl, S., additional, Veloso, J., additional, Virius, M., additional, Vondra, J., additional, Wallner, S., additional, Weisrock, T., additional, Wilfert, M., additional, ter Wolbeek, J., additional, Zaremba, K., additional, Zavada, P., additional, Zavertyaev, M., additional, Zemlyanichkina, E., additional, Zhuravlev, N., additional, Ziembicki, M., additional, and Zink, A., additional
- Published
- 2020
- Full Text
- View/download PDF
12. Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells
- Author
-
Rausch, Jessica L., primary, Ali, Areej A., additional, Lee, Donna M., additional, Gebreyohannes, Yemarshet K., additional, Mehalek, Keith R., additional, Agha, Aya, additional, Patil, Sneha S., additional, Tolstov, Yanis, additional, Wellens, Jasmien, additional, Dhillon, Harbir S., additional, Makielski, Kathleen R., additional, Debiec-Rychter, Maria, additional, Schöffski, Patrick, additional, Wozniak, Agnieszka, additional, and Duensing, Anette, additional
- Published
- 2020
- Full Text
- View/download PDF
13. A study of dynamic adsorption of propylene and ethylene emitted from the process of coal self-heating
- Author
-
Wojtacha-Rychter, Karolina, primary and Smoliński, Adam, additional
- Published
- 2019
- Full Text
- View/download PDF
14. Azimuthal asymmetries of charged hadrons produced in high-energy muon scattering off longitudinally polarised deuterons
- Author
-
C. Adolph, M. Aghasyan, R. Akhunzyanov, M. G. Alexeev, G. D. Alexeev, A. Amoroso, V. Andrieux, N. V. Anfimov, V. Anosov, K. Augsten, W. Augustyniak, A. Austregesilo, C. D. R. Azevedo, B. Badełek, F. Balestra, M. Ball, J. Barth, R. Beck, Y. Bedfer, J. Bernhard, K. Bicker, E. R. Bielert, R. Birsa, M. Bodlak, P. Bordalo, F. Bradamante, C. Braun, A. Bressan, M. Büchele, W.-C. Chang, C. Chatterjee, M. Chiosso, I. Choi, S.-U. Chung, A. Cicuttin, M. L. Crespo, Q. Curiel, S. Dalla Torre, S. S. Dasgupta, S. Dasgupta, O. Yu. Denisov, L. Dhara, S. V. Donskov, N. Doshita, Ch. Dreisbach, V. Duic, W. Dünnweber, M. Dziewiecki, A. Efremov, P. D. Eversheim, W. Eyrich, M. Faessler, A. Ferrero, M. Finger, H. Fischer, C. Franco, N. du Fresne von Vijayan Hohenesche, J. M. Friedrich, V. Frolov, E. Fuchey, F. Gautheron, O. P. Gavrichtchouk, S. Gerassimov, J. Giarra, F. Giordano, I. Gnesi, M. Gorzellik, S. Grabmüller, A. Grasso, M. Grosse Perdekamp, B. Grube, T. Grussenmeyer, A. Guskov, F. Haas, D. Hahne, G. Hamar, D. von Harrach, F. H. Heinsius, R. Heitz, F. Herrmann, N. Horikawa, N. d’Hose, C.-Y. Hsieh, S. Huber, S. Ishimoto, A. Ivanov, Yu. Ivanshin, T. Iwata, V. Jary, R. Joosten, P. Jörg, E. Kabuß, B. Ketzer, G. V. Khaustov, Yu. A. Khokhlov, Yu. Kisselev, F. Klein, K. Klimaszewski, J. H. Koivuniemi, V. N. Kolosov, K. Kondo, K. Königsmann, I. Konorov, V. F. Konstantinov, A. M. Kotzinian, O. M. Kouznetsov, M. Krämer, P. Kremser, F. Krinner, Z. V. Kroumchtein, Y. Kulinich, F. Kunne, K. Kurek, R. P. Kurjata, A. A. Lednev, A. Lehmann, M. Levillain, S. Levorato, Y.-S. Lian, J. Lichtenstadt, R. Longo, A. Maggiora, A. Magnon, N. Makins, N. Makke, G. K. Mallot, B. Marianski, A. Martin, J. Marzec, J. Matoušek, H. Matsuda, T. Matsuda, G. V. Meshcheryakov, M. Meyer, W. Meyer, Yu. V. Mikhailov, M. Mikhasenko, E. Mitrofanov, N. Mitrofanov, Y. Miyachi, A. Nagaytsev, F. Nerling, D. Neyret, J. Nový, W.-D. Nowak, G. Nukazuka, A. S. Nunes, A. G. Olshevsky, I. Orlov, M. Ostrick, D. Panzieri, B. Parsamyan, S. Paul, J.-C. Peng, F. Pereira, M. Pešek, D. V. Peshekhonov, N. Pierre, S. Platchkov, J. Pochodzalla, V. A. Polyakov, J. Pretz, M. Quaresma, C. Quintans, S. Ramos, C. Regali, G. Reicherz, C. Riedl, M. Roskot, N. S. Rossiyskaya, D. I. Ryabchikov, A. Rybnikov, A. Rychter, R. Salac, V. D. Samoylenko, A. Sandacz, C. Santos, S. Sarkar, I. A. Savin, T. Sawada, G. Sbrizzai, P. Schiavon, K. Schmidt, H. Schmieden, K. Schönning, E. Seder, A. Selyunin, L. Silva, L. Sinha, S. Sirtl, M. Slunecka, J. Smolik, A. Srnka, D. Steffen, M. Stolarski, O. Subrt, M. Sulc, H. Suzuki, A. Szabelski, T. Szameitat, P. Sznajder, S. Takekawa, M. Tasevsky, S. Tessaro, F. Tessarotto, F. Thibaud, A. Thiel, F. Tosello, V. Tskhay, S. Uhl, J. Veloso, M. Virius, J. Vondra, S. Wallner, T. Weisrock, M. Wilfert, J. ter Wolbeek, K. Zaremba, P. Zavada, M. Zavertyaev, E. Zemlyanichkina, N. Zhuravlev, M. Ziembicki, A. Zink, Institut de Recherches sur les lois Fondamentales de l'Univers (IRFU), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, COMPASS, Adolph, C., Aghasyan, M., Akhunzyanov, R., Alexeev, M. G., Alexeev, G. D., Amoroso, A., Andrieux, V., Anfimov, N. V., Anosov, V., Augsten, K., Augustyniak, W., Austregesilo, A., Azevedo, C. D. R., Badełek, B., Balestra, F., Ball, M., Barth, J., Beck, R., Bedfer, Y., Bernhard, J., Bicker, K., Bielert, E. R., Birsa, R., Bodlak, M., Bordalo, P., Bradamante, F., Braun, C., Bressan, A., Büchele, M., Chang, W. -C., Chatterjee, C., Chiosso, M., Choi, I., Chung, S. -U., Cicuttin, A., Crespo, M. L., Curiel, Q., Torre, S. Dalla, Dasgupta, S. S., Dasgupta, S., Denisov, O. Yu., Dhara, L., Donskov, S. V., Doshita, N., Dreisbach, Ch., Duic, V., Dünnweber, W., Dziewiecki, M., Efremov, A., Eversheim, P. D., Eyrich, W., Faessler, M., Ferrero, A., Finger, M., Fischer, H., Franco, C., von Vijayan Hohenesche, N. du Fresne, Friedrich, J. M., Frolov, V., Fuchey, E., Gautheron, F., Gavrichtchouk, O. P., Gerassimov, S., Giarra, J., Giordano, F., Gnesi, I., Gorzellik, M., Grabmüller, S., Grasso, A., Perdekamp, M. Grosse, Grube, B., Grussenmeyer, T., Guskov, A., Haas, F., Hahne, D., Hamar, G., von Harrach, D., Heinsius, F. H., Heitz, R., Herrmann, F., Horikawa, N., D’Hose, N., Hsieh, C. -Y., Huber, S., Ishimoto, S., Ivanov, A., Ivanshin, Yu., Iwata, T., Jary, V., Joosten, R., Jörg, P., Kabuß, E., Ketzer, B., Khaustov, G. V., Khokhlov, Yu. A., Kisselev, Yu., Klein, F., Klimaszewski, K., Koivuniemi, J. H., Kolosov, V. N., Kondo, K., Königsmann, K., Konorov, I., Konstantinov, V. F., Kotzinian, A. M., Kouznetsov, O. M., Krämer, M., Kremser, P., Krinner, F., Kroumchtein, Z. V., Kulinich, Y., Kunne, F., Kurek, K., Kurjata, R. P., Lednev, A. A., Lehmann, A., Levillain, M., Levorato, S., Lian, Y. -S., Lichtenstadt, J., Longo, R., Maggiora, A., Magnon, A., Makins, N., Makke, N., Mallot, G. K., Marianski, B., Martin, A., Marzec, J., Matoušek, J., Matsuda, H., Matsuda, T., Meshcheryakov, G. V., Meyer, M., Meyer, W., Mikhailov, Yu. V., Mikhasenko, M., Mitrofanov, E., Mitrofanov, N., Miyachi, Y., Nagaytsev, A., Nerling, F., Neyret, D., Nový, J., Nowak, W. -D., Nukazuka, G., Nunes, A. S., Olshevsky, A. G., Orlov, I., Ostrick, M., Panzieri, D., Parsamyan, B., Paul, S., Peng, J. -C., Pereira, F., Pešek, M., Peshekhonov, D. V., Pierre, N., Platchkov, S., Pochodzalla, J., Polyakov, V. A., Pretz, J., Quaresma, M., Quintans, C., Ramos, S., Regali, C., Reicherz, G., Riedl, C., Roskot, M., Rossiyskaya, N. S., Ryabchikov, D. I., Rybnikov, A., Rychter, A., Salac, R., Samoylenko, V. D., Sandacz, A., Santos, C., Sarkar, S., Savin, I. A., Sawada, T., Sbrizzai, G., Schiavon, P., Schmidt, K., Schmieden, H., Schönning, K., Seder, E., Selyunin, A., Silva, L., Sinha, L., Sirtl, S., Slunecka, M., Smolik, J., Srnka, A., Steffen, D., Stolarski, M., Subrt, O., Sulc, M., Suzuki, H., Szabelski, A., Szameitat, T., Sznajder, P., Takekawa, S., Tasevsky, M., Tessaro, S., Tessarotto, F., Thibaud, F., Thiel, A., Tosello, F., Tskhay, V., Uhl, S., Veloso, J., Virius, M., Vondra, J., Wallner, S., Weisrock, T., Wilfert, M., ter Wolbeek, J., Zaremba, K., Zavada, P., Zavertyaev, M., Zemlyanichkina, E., Zhuravlev, N., Ziembicki, M., and Zink, A.
- Subjects
virtual [photon] ,Physics and Astronomy (miscellaneous) ,Nuclear Theory ,Hadron ,140-180 GeV/c ,parton: distribution function ,Virtual particle ,muon deuteron: semi-inclusive reaction ,hadron: transverse momentum ,electroproduction [charged particle] ,transverse momentum dependence ,COMPASS ,fragmentation function ,01 natural sciences ,High Energy Physics - Experiment ,Subatomär fysik ,High Energy Physics - Experiment (hep-ex) ,longitudinal spin ,High Energy Physics - Phenomenology (hep-ph) ,semi-inclusive reaction [deep inelastic scattering] ,Subatomic Physics ,[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex] ,polarized target: longitudinal ,Nuclear Experiment ,charged particle: electroproduction ,transverse momentum [hadron] ,Physics ,deep inelastic scattering: semi-inclusive reaction ,hep-ph ,Azimuth ,High Energy Physics - Phenomenology ,TMD ,deuteron ,modulation ,Amplitude ,asymmetry [angular distribution] ,kinematics ,semi-inclusive reaction [muon deuteron] ,distribution function [parton] ,Particle Physics - Experiment ,Particle physics ,angular distribution: asymmetry ,deep inelastic scattering [muon deuteron] ,longitudinal [polarized target] ,FOS: Physical sciences ,lcsh:Astrophysics ,muon deuteron: deep inelastic scattering ,Computer Science::Digital Libraries ,energy dependence ,x-dependence ,lcsh:QB460-466 ,0103 physical sciences ,lcsh:Nuclear and particle physics. Atomic energy. Radioactivity ,ddc:530 ,010306 general physics ,Engineering (miscellaneous) ,Particle Physics - Phenomenology ,Muon ,hep-ex ,010308 nuclear & particles physics ,Scattering ,High Energy Physics::Phenomenology ,Charge (physics) ,CERN SPS ,Deep inelastic scattering ,[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph] ,fractional ,lcsh:QC770-798 ,High Energy Physics::Experiment ,photon: virtual ,experimental results - Abstract
Single hadron azimuthal asymmetries of positive and negative hadrons produced in muon semi-inclusive deep inelastic scattering off longitudinally polarised deuterons are determined using the 2006 COMPASS data and also combined all deuteron COMPASS data. For each hadron charge, the dependence of the azimuthal asymmetry on the hadron azimuthal angle $\phi$ is obtained by means of a five-parameter fitting function that besides a $\phi$-independent term includes four modulations predicted by theory: $\sin\phi$, $\sin 2 \phi$, $\sin 3\phi$ and $\cos\phi$. The amplitudes of the five terms have been extracted, first, for the hadrons in the whole available kinematic region. In further fits, performed for hadrons from a restricted kinematic region, the $\phi$-dependence is determined as a function of one of three variables (Bjorken-$x$, fractional energy of virtual photon taken by the outgoing hadron and hadron transverse momentum), while disregarding the others. Except the $\phi$-independent term, all the modulation amplitudes are very small, and no clear kinematic dependence could be observed within experimental uncertainties., Comment: 15 pages, 5 figures
- Published
- 2018
15. Evaluation of ecotoxicological impact of new pyrrole-derived aminophosphonates using selected bioassay battery
- Author
-
Diana Rogacz, Piotr Dobrzyński, Kamila Lewicka, Marta Morawska, Rafał Karpowicz, Piotr Rychter, and Jarosław Lewkowski
- Subjects
food.ingredient ,Avena ,Health, Toxicology and Mutagenesis ,Raphanus ,010501 environmental sciences ,Management, Monitoring, Policy and Law ,Biology ,Ecotoxicology ,Toxicology ,01 natural sciences ,food ,Toxicity Tests ,Botany ,Aliivibrio ,Animals ,Bioassay ,Pyrroles ,Chronic toxicity ,0105 earth and related environmental sciences ,010405 organic chemistry ,General Medicine ,biology.organism_classification ,0104 chemical sciences ,Environmental chemistry ,Biological Assay ,Phytotoxicity ,Ecotoxicity - Abstract
Six new dimethyl N-arylamino(2-pyrrolyl)methylphosphonates 2a-f were synthesized by the modified aza-Pudovik reaction. Their ecotoxicological impact using battery of bioassay was assessed using Microtox and Ostracodtoxit tests as well as phytotoxicity towards two plants, dicotyledonous radish (Raphanus sativus) and monocotyledonous oat (Avena sativa) following the OECD 208 Guideline. Ecotoxicological properties of compounds 2a-f in aspect of acute and chronic toxicity were evaluated using Heterocypris incongruens and Aliivibrio fisheri tests. The obtained results showed that tested aminophosphonates 2a-f have moderate-to-high phyto- and ecotoxicological impact. They are toxic for both plants but more toxic against dicotyledonous. The investigated compounds showed important ecotoxicity against Heterocypris incongruens crustaceans and Aliivibrio fisheri bacteria. It was found that the substituents of the phenyl ring plays a key role in the degree of toxicity. Results showed that investigated compounds are ecologically toxic and that any of their application should be implemented with care.
- Published
- 2017
16. Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts
- Author
-
Cornillie, Jasmien, primary, Wozniak, Agnieszka, additional, Van Renterghem, Britt, additional, Van Winkel, Nathalie, additional, Wellens, Jasmien, additional, Gebreyohannes, Yemarshet K., additional, Debiec-Rychter, Maria, additional, Sciot, Raf, additional, Hompes, Daphne, additional, and Schöffski, Patrick, additional
- Published
- 2019
- Full Text
- View/download PDF
17. Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification
- Author
-
Cornillie, J., primary, Wozniak, A., additional, Li, H., additional, Gebreyohannes, Y. K., additional, Wellens, J., additional, Hompes, D., additional, Debiec-Rychter, M., additional, Sciot, R., additional, and Schöffski, P., additional
- Published
- 2019
- Full Text
- View/download PDF
18. Poly(methylene-co-cyanoguanidine) as an Eco-friendly Nitrogen Fertilizer with Prolonged Activity
- Author
-
Rychter, Piotr, primary, Rogacz, Diana, additional, Lewicka, Kamila, additional, and Lacik, Igor, additional
- Published
- 2019
- Full Text
- View/download PDF
19. Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)
- Author
-
Heinrich, Michael C., primary, Patterson, Janice, additional, Beadling, Carol, additional, Wang, Yuexiang, additional, Debiec-Rychter, Maria, additional, Dewaele, Barbara, additional, Corless, Christopher L., additional, Duensing, Anette, additional, Raut, Chandrajit P., additional, Rubin, Brian, additional, Ordog, Tamas, additional, van de Rijn, Matt, additional, Call, Jerry, additional, Mühlenberg, Thomas, additional, Fletcher, Jonathan A., additional, and Bauer, Sebastian, additional
- Published
- 2019
- Full Text
- View/download PDF
20. PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors
- Author
-
Gebreyohannes, Yemarshet K., primary, Burton, Elizabeth A., additional, Wozniak, Agnieszka, additional, Matusow, Bernice, additional, Habets, Gaston, additional, Wellens, Jasmien, additional, Cornillie, Jasmien, additional, Lin, Jack, additional, Nespi, Marika, additional, Wu, Guoxian, additional, Zhang, Chao, additional, Bollag, Gideon, additional, Debiec-Rychter, Maria, additional, Sciot, Raf, additional, and Schöffski, Patrick, additional
- Published
- 2018
- Full Text
- View/download PDF
21. Lack of Evidence That Male Fetal Microchimerism is Present in Endometriosis
- Author
-
Dan I. Lebovic, Karen Peeraer, Joris Vermeesch, Rieta Van Bree, Maria Debiec-Rychter, Thomas D'Hooghe, Amelie Fassbender, Christel Meuleman, and Carla Tomassetti
- Subjects
Adult ,Male ,medicine.medical_specialty ,Ectopic endometrium ,Endometriosis ,Biology ,Endometrium ,Chimerism ,Andrology ,Risk Factors ,medicine ,Humans ,In Situ Hybridization, Fluorescence ,X chromosome ,Gynecology ,Chromosomes, Human, X ,Chromosomes, Human, Y ,medicine.diagnostic_test ,Obstetrics and Gynecology ,Microchimerism ,Original Articles ,medicine.disease ,medicine.anatomical_structure ,Case-Control Studies ,Embryology ,Etiology ,Female ,Fluorescence in situ hybridization - Abstract
Fetal microchimerism has been implicated in the etiology of autoimmune diseases. This study was done to test the hypothesis that male fetal microchimerism is present in eutopic and ectopic endometrium (EM) obtained from women with endometriosis but not in eutopic EM from women without endometriosis.A total of 31 patients were selected, including women with endometriosis (paired eutopic and ectopic EM; n = 19) and women without endometriosis (eutopic EM; n = 12). Tricolor interphase fluorescence in situ hybridization analysis was performed by cohybridization of CEP Y SpectrumAqua and CEP X SpectrumGreen (SG)/CEP Y SpectrumOrange probes.Ectopic EM from women with endometriosis had 75% XX chromosomes (double SG signals) and 25% X chromosomes (single SG signal). Y chromosomes were not observed in any of the eutopic/ectopic endometrial tissues from cases or controls.We were unable to confirm our hypothesis that male fetal microchimerism is present in eutopic and/or ectopic EM obtained from women with endometriosis.
- Published
- 2015
22. Azimuthal asymmetries of charged hadrons produced in high-energy muon scattering off longitudinally polarised deuterons
- Author
-
Adolph, C., primary, Aghasyan, M., additional, Akhunzyanov, R., additional, Alexeev, M. G., additional, Alexeev, G. D., additional, Amoroso, A., additional, Andrieux, V., additional, Anfimov, N. V., additional, Anosov, V., additional, Augsten, K., additional, Augustyniak, W., additional, Austregesilo, A., additional, Azevedo, C. D. R., additional, Badełek, B., additional, Balestra, F., additional, Ball, M., additional, Barth, J., additional, Beck, R., additional, Bedfer, Y., additional, Bernhard, J., additional, Bicker, K., additional, Bielert, E. R., additional, Birsa, R., additional, Bodlak, M., additional, Bordalo, P., additional, Bradamante, F., additional, Braun, C., additional, Bressan, A., additional, Büchele, M., additional, Chang, W.-C., additional, Chatterjee, C., additional, Chiosso, M., additional, Choi, I., additional, Chung, S.-U., additional, Cicuttin, A., additional, Crespo, M. L., additional, Curiel, Q., additional, Torre, S. Dalla, additional, Dasgupta, S. S., additional, Dasgupta, S., additional, Denisov, O. Yu., additional, Dhara, L., additional, Donskov, S. V., additional, Doshita, N., additional, Dreisbach, Ch., additional, Duic, V., additional, Dünnweber, W., additional, Dziewiecki, M., additional, Efremov, A., additional, Eversheim, P. D., additional, Eyrich, W., additional, Faessler, M., additional, Ferrero, A., additional, Finger, M., additional, Fischer, H., additional, Franco, C., additional, von Vijayan Hohenesche, N. du Fresne, additional, Friedrich, J. M., additional, Frolov, V., additional, Fuchey, E., additional, Gautheron, F., additional, Gavrichtchouk, O. P., additional, Gerassimov, S., additional, Giarra, J., additional, Giordano, F., additional, Gnesi, I., additional, Gorzellik, M., additional, Grabmüller, S., additional, Grasso, A., additional, Perdekamp, M. Grosse, additional, Grube, B., additional, Grussenmeyer, T., additional, Guskov, A., additional, Haas, F., additional, Hahne, D., additional, Hamar, G., additional, von Harrach, D., additional, Heinsius, F. H., additional, Heitz, R., additional, Herrmann, F., additional, Horikawa, N., additional, d’Hose, N., additional, Hsieh, C.-Y., additional, Huber, S., additional, Ishimoto, S., additional, Ivanov, A., additional, Ivanshin, Yu., additional, Iwata, T., additional, Jary, V., additional, Joosten, R., additional, Jörg, P., additional, Kabuß, E., additional, Ketzer, B., additional, Khaustov, G. V., additional, Khokhlov, Yu. A., additional, Kisselev, Yu., additional, Klein, F., additional, Klimaszewski, K., additional, Koivuniemi, J. H., additional, Kolosov, V. N., additional, Kondo, K., additional, Königsmann, K., additional, Konorov, I., additional, Konstantinov, V. F., additional, Kotzinian, A. M., additional, Kouznetsov, O. M., additional, Krämer, M., additional, Kremser, P., additional, Krinner, F., additional, Kroumchtein, Z. V., additional, Kulinich, Y., additional, Kunne, F., additional, Kurek, K., additional, Kurjata, R. P., additional, Lednev, A. A., additional, Lehmann, A., additional, Levillain, M., additional, Levorato, S., additional, Lian, Y.-S., additional, Lichtenstadt, J., additional, Longo, R., additional, Maggiora, A., additional, Magnon, A., additional, Makins, N., additional, Makke, N., additional, Mallot, G. K., additional, Marianski, B., additional, Martin, A., additional, Marzec, J., additional, Matoušek, J., additional, Matsuda, H., additional, Matsuda, T., additional, Meshcheryakov, G. V., additional, Meyer, M., additional, Meyer, W., additional, Mikhailov, Yu. V., additional, Mikhasenko, M., additional, Mitrofanov, E., additional, Mitrofanov, N., additional, Miyachi, Y., additional, Nagaytsev, A., additional, Nerling, F., additional, Neyret, D., additional, Nový, J., additional, Nowak, W.-D., additional, Nukazuka, G., additional, Nunes, A. S., additional, Olshevsky, A. G., additional, Orlov, I., additional, Ostrick, M., additional, Panzieri, D., additional, Parsamyan, B., additional, Paul, S., additional, Peng, J.-C., additional, Pereira, F., additional, Pešek, M., additional, Peshekhonov, D. V., additional, Pierre, N., additional, Platchkov, S., additional, Pochodzalla, J., additional, Polyakov, V. A., additional, Pretz, J., additional, Quaresma, M., additional, Quintans, C., additional, Ramos, S., additional, Regali, C., additional, Reicherz, G., additional, Riedl, C., additional, Roskot, M., additional, Rossiyskaya, N. S., additional, Ryabchikov, D. I., additional, Rybnikov, A., additional, Rychter, A., additional, Salac, R., additional, Samoylenko, V. D., additional, Sandacz, A., additional, Santos, C., additional, Sarkar, S., additional, Savin, I. A., additional, Sawada, T., additional, Sbrizzai, G., additional, Schiavon, P., additional, Schmidt, K., additional, Schmieden, H., additional, Schönning, K., additional, Seder, E., additional, Selyunin, A., additional, Silva, L., additional, Sinha, L., additional, Sirtl, S., additional, Slunecka, M., additional, Smolik, J., additional, Srnka, A., additional, Steffen, D., additional, Stolarski, M., additional, Subrt, O., additional, Sulc, M., additional, Suzuki, H., additional, Szabelski, A., additional, Szameitat, T., additional, Sznajder, P., additional, Takekawa, S., additional, Tasevsky, M., additional, Tessaro, S., additional, Tessarotto, F., additional, Thibaud, F., additional, Thiel, A., additional, Tosello, F., additional, Tskhay, V., additional, Uhl, S., additional, Veloso, J., additional, Virius, M., additional, Vondra, J., additional, Wallner, S., additional, Weisrock, T., additional, Wilfert, M., additional, ter Wolbeek, J., additional, Zaremba, K., additional, Zavada, P., additional, Zavertyaev, M., additional, Zemlyanichkina, E., additional, Zhuravlev, N., additional, Ziembicki, M., additional, and Zink, A., additional
- Published
- 2018
- Full Text
- View/download PDF
23. Clear Cell Odontogenic Carcinoma: Occurrence of EWSR1-CREB1 as Alternative Fusion Gene to EWSR1-ATF1
- Author
-
Vogels, Rob, primary, Baumhoer, Daniel, additional, van Gorp, Joost, additional, Eijkelenboom, Astrid, additional, Verdijk, Marian, additional, van Cleef, Patricia, additional, Bloemena, Elisabeth, additional, Slootweg, Pieter J., additional, Lohman, Bjorn, additional, Debiec-Rychter, Maria, additional, and Flucke, Uta, additional
- Published
- 2018
- Full Text
- View/download PDF
24. Cilostazol-Loaded Poly(ε-Caprolactone) Electrospun Drug Delivery System for Cardiovascular Applications
- Author
-
Rychter, Marek, primary, Baranowska-Korczyc, Anna, additional, Milanowski, Bartłomiej, additional, Jarek, Marcin, additional, Maciejewska, Barbara M., additional, Coy, Emerson L., additional, and Lulek, Janina, additional
- Published
- 2018
- Full Text
- View/download PDF
25. Mortality of post-settlement clams Rangia cuneata (Mactridae, Bivalvia) at an early stage of invasion in the Vistula Lagoon (South Baltic) due to biotic and abiotic factors
- Author
-
Kornijów, Ryszard, primary, Pawlikowski, Krzysztof, additional, Drgas, Aleksander, additional, Rolbiecki, Leszek, additional, and Rychter, Agata, additional
- Published
- 2018
- Full Text
- View/download PDF
26. MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours
- Author
-
Erik A.C. Wiemer, Patrick Schöffski, Antonius W. M. Boersma, Stefan Sleijfer, Caroline M.M. Gits, Ron H.J. Mathijssen, Moniek B E Jonkers, W F J van IJcken, Agnieszka Wozniak, Piotr Rutkowski, P F van Kuijk, Raf Sciot, Jaap Verweij, Takahiro Taguchi, Maria Debiec-Rychter, Medical Oncology, and Cell biology
- Subjects
Adult ,Male ,Cancer Research ,Pathology ,medicine.medical_specialty ,Carcinogenesis ,Gastrointestinal Stromal Tumors ,Apoptosis ,Cell Growth Processes ,Biology ,Transfection ,medicine.disease_cause ,ETV1 ,microRNA ,medicine ,Humans ,Molecular Diagnostics ,neoplasms ,Aged ,Aged, 80 and over ,miR-17 ,GiST ,Cell growth ,KIT ,Middle Aged ,miR-222 ,digestive system diseases ,DNA-Binding Proteins ,MicroRNAs ,Proto-Oncogene Proteins c-kit ,Oncology ,Cell culture ,Multigene Family ,Cancer research ,Female ,miR-20a ,Transcription Factors ,GIST - Abstract
BACKGROUND: Gastrointestinal stromal tumours (GIST) are characterised by high expression of KIT and ETV1, which cooperate in GIST oncogenesis. Our aim was to identify microRNAs that are deregulated in GIST, have a role in GIST pathogenesis, and could potentially be used as therapeutic tool.METHODS: Differentially expressed microRNAs between primary GIST (n=50) and gastrointestinal leiomyosarcomas (GI-LMS, n=10) were determined using microarrays. Selected microRNA mimics were transfected into GIST-882 and GIST-T1 cell lines to study the effects of microRNA overexpression on GIST cells. Luciferase reporter assays were used to establish regulation of target genes by selected microRNAs.RESULTS: MiR-17-92 and miR-221/222 cluster members were significantly (PCONCLUSION: MicroRNAs that may have an essential role in GIST pathogenesis were identified, in particular miR-17/20a/222 that target KIT and ETV1. Delivering these microRNAs therapeutically could hold great potential for GIST management, especially in imatinib-resistant disease.
- Published
- 2013
27. β-Cyclodextrin/protein conjugates as a innovative drug systems: synthesis and MS investigation
- Author
-
Janusz Boratyński, Tomasz Girek, Wojciech Ciesielski, Beata Girek, Tomasz M. Goszczyński, and Piotr Rychter
- Subjects
chemistry.chemical_classification ,Cyclodextrin ,Stereochemistry ,Chemical structure ,General Chemistry ,Protein engineering ,Condensed Matter Physics ,Combinatorial chemistry ,Matrix-assisted laser desorption/ionization ,Enzyme ,chemistry ,Drug delivery ,Drug carrier ,Food Science ,Conjugate - Abstract
The design of proteins whose structure and function can be manipulated by binding with specific ligands such as cyclodextrins, has been of great interest in the field of protein engineering and also could be used as drug delivery systems in targeted cancer therapy (Loftsson and Duchene, Int. J. Pharm. 329:1–11, 1; Loftsson et al., Expert. Opin. Drug Deliv. 2:335–351, 2). CD/proteins conjugates are synthesized using original high temperature method in which mono-6-O-formyl-β-CD reacts with two proteins: basic pancreatic trypsin inhibitor and lysozyme. The proposed synthesis method has a high reproducibility which makes it useful for pharmaceutical purposes. That method allows to obtain the conjugate without losing protein’s biological and enzymatic activity which will used in the reaction, and without violating the chemical structure of cyclodextrin molecules.
- Published
- 2012
28. A quality control program for mutation detection in KIT and PDGFRA in gastrointestinal stromal tumours
- Author
-
Fabienne Escande, Jean Michel Coindre, Silvana Pilotti, Sébastien Forget, Paolo Dei Tos, Pierre Paul Bringuier, Maria Debiec-Rychter, Elena Tamborini, David Gonzalez, Nicolas Faur, L Morzuch, Isabelle Hostein, Louisa Toffolati, Sylvianne Olschwang, Jean-François Emile, Département de pathologie, Institut Bergonié - CRLCC Bordeaux, university of leuven, Department of Human Genetics, Centre de Recherche en Cancérologie de Marseille ( CRCM ), Aix Marseille Université ( AMU ) -Institut Paoli-Calmettes-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Centre de Recherche en Cancérologie de Lyon ( CRCL ), Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), CA foncello Hospital, Department of pathology, Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Laboratoire de Physique des Lasers ( LPL ), Université Paris 13 ( UP13 ) -Université Sorbonne Paris Cité ( USPC ) -Institut Galilée-Centre National de la Recherche Scientifique ( CNRS ), biology and pathological laboratory, Laboratoire épidémiologie et oncogénèse des tumeurs digestives, Université de Versailles Saint-Quentin-en-Yvelines ( UVSQ ), Service de Pathologie, Institut Bergonié, Institut Bergonié [Bordeaux], UNICANCER-UNICANCER, UNICANCER, Radboud University Medical Center [Nijmegen], Centre de Recherche en Cancérologie de Marseille (CRCM / U891 Inserm), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physique des Lasers (LPL), Université Paris 13 (UP13)-Centre National de la Recherche Scientifique (CNRS), Medical University of Gdańsk, Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan], Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), and Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay
- Subjects
Oncology ,Receptor, Platelet-Derived Growth Factor alpha ,MESH : Polymorphism, Genetic ,MESH: Receptor, Platelet-Derived Growth Factor alpha ,DNA Mutational Analysis ,MESH: Quality Control ,MESH : Genotype ,medicine.disease_cause ,[ SDV.CAN ] Life Sciences [q-bio]/Cancer ,MESH: Genotype ,MESH : Exons ,0302 clinical medicine ,Surgical oncology ,Genotype ,MESH: DNA Mutational Analysis ,0303 health sciences ,Mutation ,MESH : Gastrointestinal Stromal Tumors ,GiST ,Gastroenterology ,MESH : Quality Control ,DNA, Neoplasm ,Exons ,3. Good health ,MESH: Proto-Oncogene Proteins c-kit ,Proto-Oncogene Proteins c-kit ,030220 oncology & carcinogenesis ,MESH: Laboratories ,MESH : DNA, Neoplasm ,MESH : Mutation ,MESH: Gastrointestinal Stromal Tumors ,Quality Control ,medicine.medical_specialty ,MESH: Mutation ,Gastrointestinal Stromal Tumors ,MESH: DNA, Neoplasm ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,MESH : DNA Mutational Analysis ,PDGFRA ,Biology ,MESH : Laboratories ,MESH : Proto-Oncogene Proteins c-kit ,03 medical and health sciences ,Internal medicine ,MESH: Polymorphism, Genetic ,medicine ,Humans ,Genotyping ,030304 developmental biology ,MESH: Humans ,Polymorphism, Genetic ,MESH : Humans ,Hepatology ,digestive system diseases ,Immunology ,MESH : Receptor, Platelet-Derived Growth Factor alpha ,MESH: Exons ,Laboratories - Abstract
International audience; BACKGROUND: Although most gastrointestinal stromal tumours (GIST) carry oncogenic mutations in KIT exons 9, 11, 13 and 17, or in platelet-derived growth factor receptor alpha (PDGFRA) exons 12, 14 and 18, around 10% of GIST are free of these mutations. Genotyping and accurate detection of KIT/PDGFRA mutations in GIST are becoming increasingly useful for clinicians in the management of the disease. METHOD: To evaluate and improve laboratory practice in GIST mutation detection, we developed a mutational screening quality control program. Eleven laboratories were enrolled in this program and 50 DNA samples were analysed, each of them by four different laboratories, giving 200 mutational reports. RESULTS: In total, eight mutations were not detected by at least one laboratory. One false positive result was reported in one sample. Thus, the mean global rate of error with clinical implication based on 200 reports was 4.5%. Concerning specific polymorphisms detection, the rate varied from 0 to 100%, depending on the laboratory. The way mutations were reported was very heterogeneous, and some errors were detected. CONCLUSION: This study demonstrated that such a program was necessary for laboratories to improve the quality of the analysis, because an error rate of 4.5% may have clinical consequences for the patient.
- Published
- 2011
29. Atypische lipomatöse Tumoren des Magens
- Author
-
W. Haarmann, Cornelius Kuhnen, Raphael Sciot, Thomas Mentzel, Maria Debiec-Rychter, and U. Schwegler
- Subjects
Pathology ,medicine.medical_specialty ,medicine.anatomical_structure ,business.industry ,Stomach ,Medicine ,business ,Pathology and Forensic Medicine - Published
- 2010
30. Gardner-Fibrom
- Author
-
Heinz-Herbert Homann, Oliver Müller, Cornelius Kuhnen, C. Lanckohr, M. Lehnhardt, Maria Debiec-Rychter, and Peter Herter
- Subjects
business.industry ,Medicine ,business ,Pathology and Forensic Medicine - Published
- 2010
31. Lipom und atypischer lipomatöser Tumor innerhalb einer Neoplasie
- Author
-
Cornelius Kuhnen, Raphael Sciot, Thomas Mentzel, Heinz-Herbert Homann, M. Lehnhardt, and Maria Debiec-Rychter
- Subjects
Gynecology ,Fluoreszenz in situ hybridisierung ,medicine.medical_specialty ,business.industry ,Medicine ,business ,Pathology and Forensic Medicine - Abstract
Der Fall eines lipomatosen Tumors mit pradominierender Lipomkomponente und Ubergang zu einem atypischen lipomatosen Tumor (ALT) vom lipomahnlichen Typ wird vorgestellt. Bei einer 70-jahrigen Patientin wurde am rechten Oberschenkel ein tief lokalisierter Weichgewebstumor mit einer maximalen Grose bis 14 cm reseziert. Korrespondierend zum makroskopischen Erscheinungsbild bot der Tumor uberwiegend das histologische Bild eines Lipoms ohne Atypie. Im restlichen Anteil (etwa 20%) fanden sich histologische Befunde eines ALT vom lipomahnlichen Typ. Immunhistochemisch war keine MDM 2-/CDK4-Expression innerhalb der Lipomkomponente, jedoch in der ALT-Komponente zu belegen. Mit Hilfe der Fluoreszenz-in-situ-Hybridisierung war keine MDM 2-Gen-Amplifikation und nur vereinzelt eine CDK4-Amplifikation innerhalb des Lipomanteils, jedoch eine deutliche Amplifikation des MDM 2-/CDK4-Gens in der ALT-Komponente nachweisbar, wodurch die morphologisch basierte Diagnose eines lipomatosen Tumors mit Arealen eines Lipoms und eines atypischen lipomatosen Tumors innerhalb einer Neoplasie zusatzlich molekularbiologisch belegt wurde. Der hier dargestellte Fall spricht fur den graduellen Ubergang eines Lipoms zu einem ALT und untermauert das Konzept einer kontinuierlichen schrittweisen Entwicklung benigner zu malignen lipomatosen Weichgewebstumoren im Sinne eines biologischen Kontinuums.
- Published
- 2010
32. Gastrointestinal Stromal Tumors
- Author
-
Maria Debiec-Rychter, Wlodzimierz Ruka, and Piotr Rutkowski
- Subjects
Pathology ,medicine.medical_specialty ,Gastrointestinal Stromal Tumors ,medicine.medical_treatment ,PDGFRA ,Targeted therapy ,Genetics ,Humans ,Medicine ,neoplasms ,Pharmacology ,GiST ,business.industry ,Sunitinib ,Imatinib ,General Medicine ,digestive system diseases ,Imatinib mesylate ,Molecular Diagnostic Techniques ,Nilotinib ,Cytogenetic Analysis ,Disease Progression ,Cancer research ,Molecular Medicine ,business ,Tyrosine kinase ,medicine.drug - Abstract
The common feature of gastrointestinal stromal tumors (GISTs) is the expression of KIT protein or acquisition of activating, constitutive mutations in the KIT or platelet-derived growth factor receptor alpha (PDGFRA) genes that are the early oncogenic events during GIST development. With these discoveries, GIST has emerged as a distinct sarcoma entity, enabling the introduction of targeted therapy using the inhibition of KIT/PDGFRA and their downstream signaling cascade. The introduction of a small-molecule tyrosine kinase inhibitor, imatinib mesylate, to clinical practice has revolutionized the treatment of patients with advanced GISTs and is currently approved as first-line treatment for patients with metastatic and/or inoperable GISTs. Mutation screening is currently a tool in GIST diagnosis, assessment of sensitivity to tyrosine kinase inhibitors, and prediction of achieving response to molecularly targeted therapy. This article discusses the histologic and molecular criteria for distinguishing GISTs from other types of sarcoma, and the molecular diagnostic tools that are currently available or in development to assist in therapy decisions.
- Published
- 2008
33. Clinical implications of mutational analysis in gastrointestinal stromal tumours
- Author
-
Ann Hoeben, Patrick Schöffski, and Maria Debiec-Rychter
- Subjects
mutational analysis ,Cancer Research ,Receptor, Platelet-Derived Growth Factor alpha ,Gastrointestinal Stromal Tumors ,medicine.drug_class ,medicine.medical_treatment ,DNA Mutational Analysis ,Reviews ,PDGFRA ,gastrointestinal stromal tumours ,Biology ,Tyrosine-kinase inhibitor ,Targeted therapy ,Risk Factors ,imatinib mesylate ,medicine ,Humans ,neoplasms ,KIT ,Imatinib ,targeted therapy ,Gastrointestinal stromal tumours ,digestive system diseases ,Mutational analysis ,Proto-Oncogene Proteins c-kit ,Imatinib mesylate ,Oncology ,Cancer research ,medicine.drug - Abstract
The management of localised and advanced gastrointestinal stromal tumours (GISTs) in terms of histological diagnosis, surgery, imaging, medical treatment and molecular biology has rapidly changed since introduction of imatinib mesylate for molecularly targeted therapy in 2000. In this minireview, we briefly summarise and discuss the current data relevant to the increasing role of molecular characterisation of GISTs in the diagnosis, risk assessment and effective targeted therapy.
- Published
- 2008
34. Evaluation of ecotoxicological impact of new pyrrole-derived aminophosphonates using selected bioassay battery
- Author
-
Lewkowski, Jarosław, primary, Morawska, Marta, additional, Karpowicz, Rafał, additional, Rychter, Piotr, additional, Rogacz, Diana, additional, Lewicka, Kamila, additional, and Dobrzyński, Piotr, additional
- Published
- 2017
- Full Text
- View/download PDF
35. Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
- Author
-
Rychter, Anna, primary, Jerzmanowski, Piotr, additional, Hołub, Adam, additional, Specht-Szwoch, Zofia, additional, Kalinowska, Violetta, additional, Tęgowska, Urszula, additional, Seferyńska, Ilona, additional, Kołkowska-Leśniak, Agnieszka, additional, Lech-Marańda, Ewa, additional, and Góra-Tybor, Joanna, additional
- Published
- 2017
- Full Text
- View/download PDF
36. MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation
- Author
-
Schaefer, Inga-Marie, primary, Wang, Yuexiang, additional, Liang, Cher-wei, additional, Bahri, Nacef, additional, Quattrone, Anna, additional, Doyle, Leona, additional, Mariño-Enríquez, Adrian, additional, Lauria, Alexandra, additional, Zhu, Meijun, additional, Debiec-Rychter, Maria, additional, Grunewald, Susanne, additional, Hechtman, Jaclyn F., additional, Dufresne, Armelle, additional, Antonescu, Cristina R., additional, Beadling, Carol, additional, Sicinska, Ewa T., additional, van de Rijn, Matt, additional, Demetri, George D., additional, Ladanyi, Marc, additional, Corless, Christopher L., additional, Heinrich, Michael C., additional, Raut, Chandrajit P., additional, Bauer, Sebastian, additional, and Fletcher, Jonathan A., additional
- Published
- 2017
- Full Text
- View/download PDF
37. Changes in energy status of leaf cells as a consequence of mitochondrial genome rearrangement
- Author
-
Anna M. Rychter, Gunilla Malmberg, Zofia Dabrowska, Bożena Szal, and Per Gardeström
- Subjects
Chloroplasts ,biology ,Nucleotides ,Plant Extracts ,Protoplasts ,fungi ,Mutant ,Wild type ,food and beverages ,Plant Science ,Protoplast ,biology.organism_classification ,Plant Leaves ,Chloroplast ,Mitochondrial respiratory chain ,Biochemistry ,Genome, Mitochondrial ,Mutation ,Tobacco ,Genetics ,NAD+ kinase ,Cucumis sativus ,Nicotiana sylvestris ,Energy Metabolism ,Nicotiana - Abstract
The MSC16 cucumber (Cucumis sativus L.) mutant with lower activity of mitochondrial Complex I was used to study the influence of mitochondrial metabolism on whole cell energy and redox state. Mutant plants had lower content of adenylates and NADP(H) whereas the NAD(H) pool was similar as in wild type. Subcellular compartmentation of adenylates and pyridine nucleotides were studied using the method of rapid fractionation of protoplasts. The data obtained demonstrate that dysfunction of mitochondrial respiratory chain decreased the chloroplastic ATP pool. No differences in NAD(H) pools in subcellular fractions of mutated plants were observed; however, the cytosolic fraction was highly reduced whereas the mitochondrial fraction was more oxidized in MSC16, as compared to WTc. The NADP(H) pool in MSC16 protoplasts was greatly decreased and the chloroplastic NADP(H) pool was more reduced, whereas the extrachloroplastic pool was much more oxidized, than in WTc protoplast. Changes in nucleotides distribution in cucumber MSC16 mutant were compared to changes found in tobacco (Nicotiana sylvestris) CMS II mitochondrial mutant. In contrast to MSC16 cucumber, the content of adenylates in tobacco mutant was much higher than in tobacco wild type. The differences were more pronounced in leaf tissue collected after darkness than in the middle of the photoperiod. Results obtained after tobacco protoplast fractionating showed that the increase in CMS II adenylate content was mainly due to a higher level in extrachloroplast fraction. Both mutations have a negative effect on plant growth through perturbation of chloroplast/mitochondrial interactions.
- Published
- 2007
38. Extramammary myofibroblastoma is genetically related to spindle cell lipoma
- Author
-
Francesca Maggiani, Guy Verbeeck, Raphael Sciot, and Maria Debiec-Rychter
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pathology ,Skin Neoplasms ,Biology ,Groin ,Pathology and Forensic Medicine ,Neoplasms, Muscle Tissue ,medicine ,Humans ,Genes, Retinoblastoma ,Mammary-Type Myofibroblastoma ,Molecular Biology ,In Situ Hybridization, Fluorescence ,Chromosome Aberrations ,Chromosomes, Human, Pair 13 ,Forkhead Box Protein O1 ,Cytogenetics ,Forkhead Transcription Factors ,Cell Biology ,General Medicine ,Mammary myofibroblastoma ,Lipoma ,medicine.disease ,Chromosomal region ,Spindle cell lipoma ,Desmin ,Myofibroblastoma - Abstract
Extramammary-type myofibroblastoma is a rare, benign spindle cell lesion, strictly resembling the breast counterpart, but occurring in extramammary sites, mainly in the inguinal/groin area. In this paper, we describe an extramammary-type myofibroblastoma in the groin of a 37-year-old male patient. The tumor showed a typical morphological and immunophenotypical profile, including staining for both CD34 and desmin. Dual-color interphase florescent in situ hybridization analysis revealed losses of RB/13q14 and FKHR/13q14 loci within tumor cells. The chromosome 13 rearrangements associated with the loss of the 13q14 chromosomal region are typically seen in spindle cell lipoma, and have been previously recognized in mammary myofibroblastoma, providing strong evidence for a pathogenetic link between these lesions.
- Published
- 2006
39. Multifocal coronary artery myocardial bridging involving the right coronary and left anterior descending arteries detected by ECG-gated 64 slice multidetector CT coronary angiography
- Author
-
John Salanitri, Kelly Rychter, and Robert R. Edelman
- Subjects
Adult ,Male ,Chest Pain ,medicine.medical_specialty ,Coronary Vessel Anomalies ,Contrast Media ,Coronary Angiography ,Chest pain ,Sudden cardiac death ,Electrocardiography ,Triiodobenzoic Acids ,medicine.artery ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Myocardial infarction ,Cardiac imaging ,medicine.diagnostic_test ,business.industry ,Middle Aged ,medicine.disease ,Coronary arteries ,medicine.anatomical_structure ,Right coronary artery ,Cardiology ,medicine.symptom ,Tomography, X-Ray Computed ,Cardiology and Cardiovascular Medicine ,business ,Artery - Abstract
Myocardial bridging is a congenital condition in which a segment of a major epicardial coronary artery has an intramyocardial course. Myocardial bridging is usually confined to a single vessel (typically the mid segment of the left anterior descending artery) and is usually asymptomatic, however, bridging may be associated with chest pain, myocardial infarction, or sudden cardiac death. While more commonly identified at autopsy, myocardial bridging is occasionally diagnosed by coronary angiography with identification of concomitant myocardial bridging involving both the left and right coronary arteries appearing to be uncommon. We present three patients presenting with atypical chest pain symptoms in whom concomitant right coronary artery and left anterior descending artery myocardial bridging was identified by ECG gated multidetector computed tomography (MDCT).
- Published
- 2006
40. Clinicopathologic markers of uterine leiomyosarcoma originating from smooth muscle tumors of low malignancy
- Author
-
Silvia Caluwaerts, Lieve Moons, Ignace Vergote, Maria Debiec-Rychter, Gökhan Tulunay, Kristel Van Calsteren, Philippe Moerman, Godelieve Verbist, and Frédéric Amant
- Subjects
Pathology ,medicine.medical_specialty ,biology ,medicine.diagnostic_test ,Cyclin A ,Obstetrics and Gynecology ,Malignancy ,medicine.disease ,Primary tumor ,Cyclin D1 ,Progesterone receptor ,Smooth Muscle Tumor ,biology.protein ,medicine ,Cancer research ,Immunohistochemistry ,Fluorescence in situ hybridization - Abstract
The aims of the study were (1) to increase the limited knowledge on molecular markers contributing to uterine leiomyosarcoma (LMS) tumorigenesis and (2) to test the ability to predict the clinical course of smooth muscle tumors of low malignancy (SMTLM). Retrospectively, 2,360 uterine smooth muscle tumors were classified according to the Stanford criteria. After central review, the clinical course of the SMTLM was traced, and immunohistochemical stainings for p53, p16, p21, Rb, estrogen receptor, progesterone receptor (PR), cyclin A, cyclin D1, vascular endothelial growth factor, WT-1, and Ki-67 were performed on paraffin-embedded tissue of the primary tumor and recurrences. On the same tissues, fluorescence in situ hybridization (FISH) analysis was performed to determine differences in HMGA2, p53, Rb, and 1p36 loci involvement. Five SMTLM were identified, of which two relapsed after 2 and 3 years, respectively. Recurrence tumors were surgically resected, and 3 years later, both patients are alive and there is no evidence for progression of disease. The age at diagnosis in the group with benign course was lower (39, 40, 43 years) than that in the group that recurred (48, 53 years). Both recurrent SMTLMs expressed less PR and, only quantitatively, more p53. One case expressed more cyclin D1 when compared to its primary. p16 level was reduced in one recurrent SMTLM. FISH of both SMTLMs that recurred revealed homozygous deletion of p53 and Rb loci in one of each primary and recurrent tumor. Loss of 1p36 loci was found in both recurrent SMTLMs, and in one case, this genetic imbalance was already present in the primary tumor. The current data provide evidence that the age at diagnosis of SMTLM is a prognostic factor and that LMS originating from SMTLM carries an overall better prognosis than primary LMS. Recurrent tumors showed decreased PR levels. Accumulation of genetic losses, including p53, Rb, and 1p36 loci, may identify a subgroup of SMTLMs with a higher potential towards malignancy.
- Published
- 2005
41. Changes in the concentration of phenolic compounds and exudation induced by phosphate deficiency in bean plants (Phaseolus vulgaris L.)
- Author
-
Anna Wiktorowska, Anna M. Rychter, Izabela M. Juszczuk, and Eligio Malusà
- Subjects
Exudate ,Ecophysiology ,biology ,food and beverages ,Soil Science ,Plant physiology ,Plant Science ,Phenylalanine ammonia-lyase ,Phosphate ,biology.organism_classification ,chemistry.chemical_compound ,Horticulture ,Nutrient ,chemistry ,Anthocyanin ,Botany ,medicine ,medicine.symptom ,Phaseolus - Abstract
The effect of prolonged phosphate starvation of bean plants (Phaseolus vulgaris L.) on the concentration of phenolics and their exudation by roots was studied. Plants cultured on phosphate-deficient media maintained a steady concentration of total phenolics in the leaves, whereas in the leaves of plants grown on complete nutrient media the phenolic concentration decreased. After 18 days of culture, higher total phenolics and anthocyanin concentrations in phosphate-deficient leaves compared with control leaves were observed. The divergent trends in total phenolic concentrations between phosphate-deficient and control leaves corresponded to the changes in the activity of L-phenylalanine ammonia-lyase. In the roots, the concentration of total phenolics was lower in phosphate-deficient plants compared with control plants. However, after 18 days of culture of bean plants, the amount of exuded phenolics from phosphate-deficient roots was 5-times higher than that from the roots of control plants. The activity of L-phenylalanine ammonia-lyase was twice as high in the roots of phosphate-starved plants. Comparable rates in the exudation of phenolics by bean roots observed after 18 days of culture on nitrogen-deficient or phosphate-deficient medium may suggest a similar system of signal transduction for phenolics release. The results are discussed in relation to the possible functions of phenolics in nutrient uptake and as chemical signals in root-soil microbe interactions to enhance the plant adaptation to particular environmental conditions.
- Published
- 2004
42. A phase II trial with rosiglitazone in liposarcoma patients
- Author
-
V Vanhentenrijk, Raymond Oyen, Maria Debiec-Rychter, A. van Oosterom, Raf Sciot, and G Debrock
- Subjects
Adult ,Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,PPARγ ,medicine.drug_class ,Receptors, Cytoplasmic and Nuclear ,Peroxisome proliferator-activated receptor ,Liposarcoma ,Microbodies ,Rosiglitazone ,Clinical ,Fibrinolytic Agents ,Internal medicine ,Humans ,Medicine ,Thiazolidinedione ,chemistry.chemical_classification ,Myxoid liposarcoma ,business.industry ,Nuclear Proteins ,Troglitazone ,Zinc Fingers ,Middle Aged ,medicine.disease ,DNA-Binding Proteins ,Gene Expression Regulation, Neoplastic ,Repressor Proteins ,Treatment Outcome ,Endocrinology ,chemistry ,Disease Progression ,Female ,Thiazolidinediones ,Sarcoma ,business ,Fibrinolytic agent ,Transcription Factors ,medicine.drug - Abstract
Agents of the thiazolidinedione drug family can terminally differentiate human liposarcoma cells in vitro by activating genes responsible for lipocyte differentiation. One study has shown clinical activity of troglitazone treatment in liposarcoma patients. We sought to find further evidence for this result. In all, 12 patients with a liposarcoma received rosiglitazone 4 mg b.d. They were followed clinically and with repeated biopsies for histological and biological studies. At the molecular level the mRNA translation of three genes that are induced by this treatment (peroxisome proliferator-activated receptor gamma (PPARgamma), adipsin and fatty acid binding protein) was determined. Nine patients were eligible for evaluation. One patient had to stop treatment due to hepatotoxicity. The mean time to progression was 6 months (2 - 16 months), with one patient still on treatment. We did not see any significant change in histologic appearance of the liposarcomas by the treatment. The level of gene expression changed significantly in two patients, but this did not result in a clinical response. Based on this study, rosiglitazone is not effective as an antitumoral drug in the treatment of liposarcomas. Increased PPARgamma activity does not correlate with the clinical evolution.
- Published
- 2003
43. [Untitled]
- Author
-
Maria Debiec-Rychter, Bartosz Wasag, Agnieszka Wozniak, D. Gasecki, Jerzy Lasota, Ewa Izycka-Swieszewska, Jacek Bartkowiak, Janusz Limon, and Katarzyna Plata-Nazar
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,breakpoint cluster region ,Biology ,medicine.disease ,Loss of heterozygosity ,Neurology ,Oncology ,Primitive neuroectodermal tumor ,Atypical teratoid rhabdoid tumor ,medicine ,Missense mutation ,Neurology (clinical) ,Teratoma ,Neuroectodermal tumor ,Chromosome 22 - Abstract
This report describes the clinical, pathological, immunohistochemical and genetic data of two rare malignant neoplasms of the central nervous system (CNS)--a cerebral atypical teratoid/rhabdoid tumor (AT/RT) in a 5-month-old girl and a spinal canal primitive neuroectodermal tumor (PNET) in her father. Despite aggressive treatment, both tumors were fatal, displaying extensive local recurrence and diffuse neoplastic dissemination. The paraffin-embedded tumor tissue samples were analyzed using a dual-color FISH with a locus specific LSI22q (BCR) probe. In the AT/RT tissue, a loss of BCR locus was observed in a significant proportion of the cells in contrast to the PNET specimen where the majority of nuclei did not reveal any loss of the BCR region. No mutations in exon 5 and no changes in SNP of intron 5 of hSNF/INI1 gene were found. In addition, analysis of loss of heterozygosity (LOH) was performed using a panel of 15 microsatellite markers of chromosome 22. No LOH were found in both tumor tissues. In both cases no constitutional mutations of gene TP53 were found. Analysis of the TP53 mutations in the tumor tissues revealed that the PNET, not the AT/RT tumor, was homozygous for a missense mutation at codon 175 (CGC ==> CAC). Thus, our findings emphasize the genetic differences between the two specimens and suggest that the occurrence of these two aggressive tumors of CNS in one family could be coincidental.
- Published
- 2003
44. Atypical lipomatous tumor in a 14-year-old patient: distinction from lipoblastoma using FISH analysis
- Author
-
Maria Debiec-Rychter, Cornelius Kuhnen, Thomas Mentzel, Annette Fisseler-Eckhoff, and Raphael Sciot
- Subjects
Pathology ,medicine.medical_specialty ,Adolescent ,Round Cell Liposarcoma ,Liposarcoma ,Biology ,Pathology and Forensic Medicine ,Atypical Lipomatous Tumor ,Diagnosis, Differential ,Proto-Oncogene Proteins ,medicine ,Humans ,neoplasms ,Molecular Biology ,In Situ Hybridization, Fluorescence ,Gene Rearrangement ,Polysomy ,medicine.diagnostic_test ,Cyclin-Dependent Kinase 4 ,Cell Biology ,General Medicine ,Anatomy ,Gene rearrangement ,Lipoma ,medicine.disease ,Cyclin-Dependent Kinases ,DNA-Binding Proteins ,body regions ,Female ,Lipoblastoma ,Fluorescence in situ hybridization - Abstract
Liposarcomas are rare in young age. We present the rare case of an atypical lipomatous tumor (synonym: well-differentiated lipoma-like liposarcoma) in a 14-year-old girl with the differential diagnosis of lipoblastoma which was excluded by fluorescence in situ hybridization (FISH) analysis. The tumor presented as a soft tissue mass at the dorsal part of the right thigh measuring up to 18 cm. Microscopically the lesion consisted of atypical adipocytes with hyperchromatic nuclei and additional multivacuolated lipoblasts. Interphase dual-color FISH performed with chromosome 8 centromeric and YAC164H5 (mapping to exons 2-5 of the PLAG1 gene) probes revealed no rearrangement of PLAG1 oncogene or polysomy of chromosome 8. Additional FISH using an MDM2 gene probe and an BAC534N15 probe (containing sequences specific for the CDK4 gene) showed amplification of the CDK4 gene. These findings indicate that this tumor was no lipoblastoma but an atypical lipomatous tumor, which is of clinical relevance. In young individuals the distinction between lipoblastoma and liposarcoma is often impossible by light microscopy alone. This case shows that FISH can serve as a decisive tool in the differential diagnosis of lipoblastoma and lipoma-like liposarcoma apart from its role in distinction between lipoblastoma and myxoid/round cell liposarcoma.
- Published
- 2002
45. Aneurysmal bone cyst of the nose with 17p13 involvement
- Author
-
Maria Debiec-Rychter, Mark Jorissen, Raphael Sciot, Sofie Bogaerts, and V. Winnepenninckx
- Subjects
medicine.medical_specialty ,Pathology ,Chromosomal translocation ,In situ hybridization ,Biology ,Translocation, Genetic ,Pathology and Forensic Medicine ,Putative gene ,Paranasal Sinus Diseases ,medicine ,Humans ,Child ,Molecular Biology ,In Situ Hybridization, Fluorescence ,Nose ,medicine.diagnostic_test ,Cytogenetics ,Magnetic resonance imaging ,Cell Biology ,General Medicine ,Anatomy ,Aneurysmal bone cyst ,medicine.disease ,Magnetic Resonance Imaging ,Bone Cysts, Aneurysmal ,medicine.anatomical_structure ,Karyotyping ,Female ,Chromosomes, Human, Pair 17 - Abstract
We report on a 6-year-old girl with a polypoid mass, filling up the entire right nasal cavity as shown on a magnetic resonance imaging scan. Histologically, the tumor had the characteristics of an aneurysmal bone cyst, which is extremely rare in this location. Cytogenetic analysis disclosed a single (6:17)(p21;p13) translocation, confirming a specific genetic involvement in the development of aneurysmal bone cysts. Fluorescent in situ hybridization analysis mapped the putative gene between the p53 (17p13.1) and the Mieller-Dieker gene (17p13.3) loci.
- Published
- 2001
46. Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes
- Author
-
P. Guelinckx, Isabelle Lambert, Anne Hagemeijer, Raf Sciot, and Maria Debiec-Rychter
- Subjects
Pathology ,medicine.medical_specialty ,Fibrosarcoma ,Soft Tissue Neoplasms ,Chromosomal translocation ,Biology ,Translocation, Genetic ,Pathology and Forensic Medicine ,Immunoenzyme Techniques ,Complex Karyotype ,Biomarkers, Tumor ,medicine ,Humans ,Hemosiderotic Fibrolipomatous Tumor ,Molecular Biology ,In Situ Hybridization, Fluorescence ,medicine.diagnostic_test ,Foot ,Chromosome Fragility ,Breakpoint ,Cytogenetics ,Karyotype ,Cell Biology ,General Medicine ,Middle Aged ,medicine.disease ,Clone Cells ,Neoplasm Proteins ,Mucus ,Karyotyping ,Female ,Sarcoma ,Chromosome Deletion ,Fluorescence in situ hybridization - Abstract
Acral myxoinflammatory fibroblastic sarcoma is a rare tumor of the distal extremities. We present the hitherto unreported karyotypic abnormalities of this new entity. The tumor presented as a mass in the dorsum of the foot in a 53-year-old woman and showed the typical virocyte-like and lipoblast-like cells in a myxoid and inflammatory background. Cytogenetic analysis revealed a complex karyotype with a reciprocal translocation t(1;10) (p22;q24) in addition to the loss of chromosomes 3 and 13. Fluorescence in situ hybridization with the 769E11YAC and BAC 31L5 and 2H23 probes showed the breakpoint to be located proximally to BCL10 and distally to GOT1 genes on chromosomes 1p22 and 10q24, respectively. The presence of these clonal chromosomal changes supports the neoplastic nature of acral myxoinflammatory fibroblastic sarcoma and underscores that it represents a separate entity.
- Published
- 2001
47. Angiomyxolipoma shares cytogenetic changes with lipoma, spindle cell/pleomorphic lipoma and myxoma
- Author
-
Anne Hagemeijer, Raf Sciot, Ivo De Wever, and Maria Debiec-Rychter
- Subjects
medicine.medical_specialty ,Pathology ,Angiomyolipoma ,Angiolipoma ,Antigens, CD34 ,Biology ,Translocation, Genetic ,Pathology and Forensic Medicine ,Immunoenzyme Techniques ,medicine ,Humans ,Molecular Biology ,Ultrasonography ,Chromosome Aberrations ,Chromosomes, Human, Pair 12 ,Chromosomes, Human, Pair 13 ,business.industry ,Cytogenetics ,Myxoma ,Karyotype ,Cell Biology ,General Medicine ,Anatomy ,Middle Aged ,Lipoma ,medicine.disease ,Spindle Cell/Pleomorphic Lipoma ,Karyotyping ,Female ,Tomography, X-Ray Computed ,business ,Chromosomes, Human, Pair 7 ,Chromosomes, Human, Pair 8 - Abstract
Angiomyxolipoma is a rare variant of lipoma, two cases of which have recently been described. We report on the hitherto unreported clonal chromosomal changes of a third case of angiomyxolipoma. The karyotype showed a 46,XX,t(7;13)(p15;q14),t(8;12)(q13;p13)[17]/46,XX[3]. The involvement of 13q14, 12p13, and 8q13 supports a relationship with other types of benign lipomatous and myxoid tumors.
- Published
- 2001
48. The effect of phosphate deficiency on membrane phospholipid composition of bean (Phaseolus vulgaris L.) roots
- Author
-
Bożena Szal, Anna M. Rychter, and Agnieszka Gniazdowska
- Subjects
Phosphatidylethanolamine ,Chromatography ,Physiology ,Phospholipid ,Plant Science ,Phosphatidic acid ,Biology ,Phosphate ,biology.organism_classification ,chemistry.chemical_compound ,Membrane ,Lysophosphatidylcholine ,chemistry ,Biochemistry ,Phosphatidylcholine ,lipids (amino acids, peptides, and proteins) ,Phaseolus ,Agronomy and Crop Science - Abstract
Plasma membranes were isolated from roots of bean (Phaseolus vulgaris L.) plants cultured on phosphate sufficient or phosphate deficient medium. The phospholipid composition of plasma membranes was analyzed and compared with that of the microsomal fraction. Phosphate deficiency had no influence on lipid/protein ratio in microsomal as well as plasma membrane fraction. In phosphate deficient roots phospholipid content was lower in the plasma membrane, but did not change in the microsomal fraction. Phosphatidylcholine and phosphatidylethanolamine were two major phospholipids in plasmalemma and microsomal membranes (80 % of the total). After two weeks of phosphate starvation a considerable decrease (about 50 %) in phosphatidylcholine and phosphatidylethanolamine in microsomal membranes was observed. The decline in two major phospholipids was accompanied by an increase in phosphatidic acid and lysophosphatidylcholine content. The effect of alterations in plasma membrane phospholipids on membrane function e.g. nitrate uptake is discussed.
- Published
- 1999
49. Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease
- Author
-
Heleniak, Zbigniew, primary, Cieplińska, Magdalena, additional, Szychliński, Tomasz, additional, Rychter, Dymitr, additional, Jagodzińska, Kalina, additional, Kłos, Alicja, additional, Kuźmiuk, Izabela, additional, Tylicka, Marzena Jakimowicz, additional, Tylicki, Leszek, additional, Rutkowski, Bolesław, additional, and Dębska-Ślizień, Alicja, additional
- Published
- 2016
- Full Text
- View/download PDF
50. Differential protein expression profile in gastrointestinal stromal tumors
- Author
-
Raphael Sciot, E. A. de Bruijn, A.T. Van Oosterom, Maria Debiec-Rychter, Hans Prenen, and B. Landuyt
- Subjects
Pathology ,medicine.medical_specialty ,Stromal cell ,Gastrointestinal Stromal Tumors ,Clinical Biochemistry ,Biology ,Proteomics ,medicine.disease_cause ,Biochemistry ,Mass Spectrometry ,Exon ,symbols.namesake ,medicine ,Humans ,Oncogene KIT ,neoplasms ,Mutation ,Organic Chemistry ,Proteins ,Imatinib ,Exons ,digestive system diseases ,Interstitial cell of Cajal ,Proto-Oncogene Proteins c-kit ,symbols ,Human medicine ,medicine.drug - Abstract
Gastrointestinal stromal tumors (GISTs) arise from the interstitial cells of Cajal through gain of function mutations of the oncogene KIT. Imatinib offers the first effective treatment for patients with GISTs, but the therapeutic outcome strongly depends on the type of KIT mutation. We used ProteinChip technology to investigate whether GISTs with different KIT mutations express different proteins. In total, 154 proteins were significantly differentially expressed in GISTs with exon 9 KIT mutation compared to GISTs with exon 11 KIT mutation.
- Published
- 2004
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.